The control of swine influenza virus (SIV) infection is paramount for increasing the productivity of pig farming and minimizing the threat of pandemic outbreaks. Thus, SIV surveillance should be conducted by region and on a regular basis. Here, we established a microneutralization assay specific for SIV seroprevalence surveillance by using reporter gene-expressing recombinant influenza viruses. Growth-based SIV seroprevalence revealed that most sows and piglets were positive for neutralizing antibodies against influenza viruses. In contrast, the 90-day-old growing pigs exhibited limited neutralizing activity in their sera, suggesting that this particular age of population is most susceptible to SIV infection and thus is an ideal age group for SIV isolation. From nasal swab specimens of healthy pigs in this age population, we were able to isolate SIVs at a higher incidence (5.3%) than those of previous reports. Nucleotide sequencing and phylogenetic analysis of the hemagglutinin (HA) genes revealed that the isolated SIVs have circulated and evolved in pigs but not have been recently introduced from humans, implying that a large number of SIV lineages may remain "undiscovered" in the global porcine populations. We propose that the 90-day-old growing pig-targeted nasal swab collection presented in this study facilitates global SIV surveillance and contributes to the detection and control of SIV infection.
S
wine influenza viruses (SIVs) have occasionally caused severe epidemics with the abortions and deaths of pigs (1) (2) (3) and are now found in pig populations globally. Coinfections with other pathogens, such as porcine reproductive and respiratory syndrome virus (4) or Mycoplasma hyopneumoniae (5) , have been demonstrated to aggravate clinical outcomes of SIV-infected pigs. In addition, SIVs are considered some of the most important pathogens for public health, since pigs have the potential to act as a "mixing vessel" for creating novel reassortant influenza viruses that may cause influenza pandemics (6) due to their high susceptibility to both avian and human influenza viruses (7, 8) . Pandemic (H1N1) 2009 [A(H1N1)pdm09] is indeed thought to have arisen from a single reassortment or several reassortments among multiple SIV strains that were originally established by cross-species infections with avian and human influenza viruses in pig populations (9) . The detection and control of SIV infections, therefore, should contribute to both increasing the productivity of pig farming and minimizing the threat of pandemic outbreaks.
Currently, influenza A viruses of the H1N1, H1N2, and H3N2 subtypes are globally isolated from pigs (10) . However, genetically and antigenically distinct virus lineages have been individually established in North America, Asia, and Europe (11) likely due to the limited intercontinental transport of pigs, unlike those of humans or wild aquatic birds. In Japan, SIVs of A(H1N1)pdm09 virus-derived H1N1, the so-called "classical swine virus lineagederived H1N2" and North American "triple reassortant" H3N2 subtypes have been isolated recently (12) , although the last H3N2 virus was isolated from a pig imported from Canada during animal quarantine and is not considered a circulating strain in Japan. Thus, SIV surveillance should be conducted in all regions and on a regular basis. Nevertheless, circulating SIVs have not been monitored closely enough; in fact, although the genetic information allowed the suggestion that the A(H1N1)pdm09 was caused by swine-origin influenza viruses, their ancestral virus lineages had not been isolated from pigs. Therefore, it is critical that SIV surveillance be globally facilitated.
Here, we reveal a growing stage-based SIV seroprevalence in pig populations by using replication-incompetent reporter geneexpressing influenza viruses generated previously (13) . We then found the age group of pigs suitable for SIV isolation. The specimen collection targeted for this particular age group did indeed allow efficient SIV isolation.
MATERIALS AND METHODS
Serum and nasal swab collections from pigs. All pig farms involved in this study were located in southern Japan. A total of 129 blood specimens were collected from pigs ranging in growing stages from 30-day-old piglets to sows experiencing farrows more than four times in a pig farm (farm A) in July and November 2012 (Table 1) , processed for serum separation by a standard method, and stored at Ϫ30°C until use. Nasal swabs were collected from a small number (about 10 specimens on each farm for a total of 209 specimens) of healthy pigs ranging in age from 90 to 120 days once on five pig farms (farms B to F), twice on five pig farms (farms G to K) in May and/or August to September 2013, and five times on in a pig farm (farm L) in August to November 2013. None of the pigs involved in this study received SIV vaccines.
Cells. Human embryonic kidney 293T cells were maintained in Dulbecco's modified Eagle medium (Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented with 10% fetal calf serum. AX4/PB2 cells, a derivative of Madin-Darby canine kidney (MDCK) cells, into which both the gene for human ␣-2,6-sialyltransferase and the PB2 gene from the influenza A virus laboratory strain A/Puerto Rico/8/34 (H1N1) stably expressed (13, 14) , were maintained in minimum essential medium (MEM) supplemented with 5% newborn calf serum, puromycin (2 g/ ml), and blasticidin (10 g/ml). Virus-inoculated AX4/PB2 cells were cultured in MEM containing 0.3% bovine serum albumin (MEM-BSA) with 1 g/ml tolylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin. All cells were incubated at 37°C in 5% CO 2 .
Recombinant influenza viruses. The influenza A virus laboratory strain A/WSN/33(H1N1) (WSN)-based PB2 gene-knockout (PB2KO) green fluorescent protein (GFP)-expressing influenza viruses with hemagglutinin (HA) genes from various SIV-related strains (Table 2) were generated by plasmid-based reverse genetics (15) as described previously (13 (16) , which contains the WSN-derived 3= PB2 noncoding region, 120 nucleotides of the PB2 coding sequence at the 3= end, the GFP coding sequence, and 336 nucleotides of the PB2 coding sequence at the 5= end and the 5= PB2 noncoding region, and for the remaining six (i.e., PB1, PA, NP, NA, M, and NS) genes from the WSN strain. Simultaneously, the cells were also cotransfected with plasmids for the expression of WSN-derived PB2, PB1, PA, and NP proteins. The culture supernatants containing transfectant viruses were harvested at 48 h posttransfection and inoculated into AX4/ PB2 cells to confirm the GFP expression in virus-infected cells and to propagate viruses. At 48 to 72 after inoculation, the culture supernatants containing propagated viruses were harvested, clarified, aliquoted, and stored at Ϫ80°C until use. Titers of the stock viruses were determined by the use of 50% tissue culture infective dose (TCID 50 ) assays in AX4/PB2 cells.
Microneutralization assay. The neutralizing activity of serum specimens from pigs was determined by using PB2KO virus-based microneutralization assays as described previously (13) . Briefly, pig sera were treated with receptor-destroying enzyme (RDE II; Denka Seiken Co., Ltd., Tokyo, Japan) to remove inhibitors of influenza virus replication and serially diluted (2-fold dilutions, from 10-to 10 ϫ 2 7 -fold) with MEM- BSA. The diluted sera were mixed with 200 TCID 50 each of the PB2KO viruses, incubated at 37°C for 1 h, and inoculated into AX4/PB2 cells. Twenty-four hours later, the neutralization activity was determined on the basis of the GFP expression observed under a fluorescence microscope (Eclipse Ti-S; Nikon, Tokyo, Japan). SIV isolation. Nasal swab specimens from pigs were inoculated into the allantoic cavity of 9-to 11-day-old embryonated chicken eggs and incubated at 37°C for 2 to 3 days. The harvested allantoic fluids were subjected to a fluorescent immunochromatography-based influenza diagnostic device that was specifically modified for detection of influenza A viral nucleoprotein, while the original device was specific for the H5 HA detection (17) . The virus-positive allantoic fluids were aliquoted and stored at Ϫ80°C until use.
Sequence analysis. RNAs in the virus-positive allantoic fluids were extracted with a high pure viral nucleic acid kit (Roche, Basel, Switzerland) and reverse transcribed with SuperScript III reverse transcriptase (Thermo Fisher Scientific, Waltham, MA), according to the manufacturer's instructions. By using the cDNA products as templates, HA genes were amplified by PCR with Phusion hot start II high-fidelity DNA polymerase (Thermo Fisher Scientific). Nucleotide sequences of the HA genes were determined by using the BigDye Terminator sequencing kit, version 3.1 (Thermo Fisher Scientific) and Applied Biosystems 3500xL genetic analyzer (Thermo Fisher Scientific). Primer sequences are available upon request.
Phylogenetic analysis. The nucleotide sequences of the full-length H1 and H3 HA genes from all avian and swine viruses available in the GISAID EpiFlu database (http://platform.gisaid.org/) were trimmed by the closest-neighbor trimming method (18) to thin out densely sampled sequences without the sampling bias. The resultant reassembled data sets (286 and 201 sequences for H1 and H3 HA genes, respectively) together with the counterparts from the SIVs isolated in this study and from representative human viruses were phylogenetically analyzed by using the maximum likelihood method in MEGA 6 software (19) with a bootstrapping set of 100 replicates.
Nucleotide sequence accession numbers. The nucleotide sequences determined globally were deposited in GenBank under the accession numbers shown in Table 3 .
RESULTS AND DISCUSSION
Seroprevalence of SIV in pigs from a broad range of growing stages. To evaluate the SIV epidemic situation in pig populations, analyzing serological evidence of infection with antigenically distinct representative virus strains in a large number of pigs is critical. The primary target of neutralizing antibodies against influenza viruses is one of the surface glycoproteins, hemagglutinin (HA): the HA antigenicity allows influenza A viruses to be classified into 16 HA subtypes (20) . Viruses of H1 and H3 HA subtypes have been globally and constantly isolated from pigs and thus are considered major SIV lineages (21) . In contrast, H4 viruses were sporadically isolated from pigs (22, 23) , suggesting their potential for natural infection in pigs and their limited transmissibility in pig populations.
To determine the neutralizing activity of pig sera against antigenically distinct influenza A viruses efficiently, we established a microneutralization assay specific for SIV seroprevalence surveillance by using PB2 gene-knockout (PB2KO) green fluorescent protein (GFP)-expressing influenza viruses, which were recently generated by means of plasmid-based reverse genetics (15) and demonstrated to enable the detection of neutralizing antibodies with higher sensitivity compared with that of conventional microneutralization assays (13) . In the current study, we generated A/WSN/33(H1N1)-based GFP-expressing PB2KO viruses that possessed the HA gene from the reference strains of the H1, H3, or H4 virus subtype (Table 2) . We also prepared the PB2KO virus counterparts with the HA gene from the H1 or H3 subtype SIV vaccine strain or from an early isolate of the A(H1N1)pdm09 viruses that are now thought to have been reintroduced into pig populations globally (24) (25) (26) (27) (28) (29) (30) (31) , including in Japan (12) ( Table 2) . Because the replication of these reporter gene-expressing recombinant viruses is restricted to PB2 protein-expressing cells (13) , this improved assay allows not only efficient but also biologically contained detection of neutralizing antibodies.
To clarify the age-based seroprevalence in pig populations, sera from healthy and nonvaccinated pigs from a broad range of growing stages were collected on farm A, Japan, in 2012. Totals of 62 and 67 specimens were collected in July and November, respectively (Table 1) , and subjected to the modified microneutralization assays. The neutralizing activity of the pig sera against each PB2KO virus was determined based on the GFP expression in the inoculated cells.
Although none of the sera tested showed neutralizing activity against the H4 virus, the rest of the viruses were neutralized by some of the pig sera (Fig. 1) . Because the difference among the PB2KO viruses was only their HA genes, these results indicate that the neutralizing activity detected in this assay was solely dependent on the HA antigenicity. Among the PB2KO viruses tested, the virus possessing A(H1N1)pdm09 virus-derived HA was prominent in both the positive ratio and neutralizing titer (Fig. 1) , implying that SIVs whose HA antigenicities are close to those of A(H1N1)pdm09 viruses spread widely and thus most likely reflect the SIV dynamics in pig populations.
Intriguingly, most sera from sows showed relatively high neutralizing activity against at least one of the PB2KO viruses. Furthermore, parity numbers showed a positive correlation with neutralizing activity and a positive ratio. These results suggest that sows that have lived longer experienced influenza virus infections multiple times and thus their humoral immunity against influenza viruses was boosted. Similar to sows, most 30-day-old piglets were demonstrated to have neutralizing antibodies against influenza A viruses; however, these antibodies were not likely to have been elicited by virus infection but may have been provided from their sows as maternal antibodies. It is noteworthy that little neutralizing activity, even against the A(H1N1)pdm09 virus-derived HA, was detected in sera from 90-day-old growing pigs. These results highlight the observation that this age population is most susceptible to influenza A virus infection. In fact, a previous report (32) noted that maternal antibodies against SIVs were detectable in pigs up to 10 weeks old.
No significant differences were observed in the overall seroprevalence patterns between the two periods of sample collection, suggesting that some naive pigs (e.g., the 90-day-old growing pigs) in July were infected with influenza A viruses during the July to November period. These findings suggest that SIVs circulate in pig populations even in the summer seasons.
SIV isolation by age-targeted specimen collection. The over- all seroprevalence data suggest that 90-day-old growing pigs are suitable for SIV isolation in any season (Fig. 1) . To confirm that the pigs in this particular age population are suitable for SIV isolation, we collected nasal swabs from pigs ranging in age from 90 to 120 days in 11 pig farms (farms B to L) in May and/or August to September 2013. The nasal swab specimens were inoculated into embryonated chicken eggs for virus isolation. SIVs were isolated from a total of 11 specimens from three pig farms; three specimens collected in May 2013 from farm B, one specimen collected in September 2013 from farm C, and seven specimens collected in September 2013 from farm L (Fig. 2) . The SIV isolation rate of our study reached 5.3% (11/209 specimens). The isolation rates of SIVs in previous reports were limited, although considerable efforts have been made for the SIV surveillance. Zhu et al. (30) isolated 36 SIVs (0.1%) from a total of 3,600 tracheal swabs collected from slaughtered pigs. Even by active nasal swab collection from growing pigs at pig farms, the SIV isolation rates were only 1.1% (178/16,170 specimens) (33) and 1.6% (12/731 specimens) (34) . These findings highlight the fact that our age-targeted nasal swab collection allows efficient and specific SIV isolation.
Note that all SIV-positive specimens from farm L were collected at a single time point, although the specimens in farm L were collected five times over 70 days. In addition, the SIV-positive ratio of this sample population reached 46.7% (7/15 specimens). These results suggest that active SIV transmission occurs intermittently, rather than continuously, among naive pig populations.
Phylogenetic characterization of the isolated SIVs. The HA subtype of all the isolated SIVs was determined by means of the standard hemagglutination inhibition (HI) assays, revealing that the isolates from farm B were the H3 subtype, and the rest of the isolates were the H1 subtype. Notably, the isolates from the same farms were antigenically indistinguishable by HI assays (data not shown), suggesting that SIVs isolated from farms B and L and likely also from farm C, were epidemic strains in each farm. By sequencing the HA and NA genes of the representative isolates in each farm, we revealed that the isolates from farm B were the H3N2 subtype [A/swine/Japan/KU-MD4/2013(H3N2) (MD4 virus)] and the isolates from farms C and L were the H1N1 subtype [A/swine/Japan/KU-HY5/2013(H1N1) (HY5 virus) and A/swine/ Japan/KU-YG5/2013(H1N1) (YG5 virus), respectively] ( Table 3) .
To clarify the genetic relationships of the HA genes of the three representative isolates with the counterparts of swine, human, and avian isolates, the determined HA gene sequences were phylogenetically analyzed. The phylogenetic tree of the H3 HA genes (Fig.  3 ) revealed that MD4 virus is genetically distinct from general swine H3 virus lineages, such as the so-called "human-like swine H3N2 viruses" (35) (36) (37) (38) (39) (40) circulating in Europe and Asia or "triple reassortant viruses" (2, 3) circulating in North America. In fact, an H3 human isolate in the 1999-2000 influenza season, A/New York/179/1999(H3N2), shows the highest homology (94.8%) to MD4 virus in the HA gene sequences (Table 3 ). In addition, a swine virus isolated in Japan in 2000, A/swine/Nagano/2000 (H3N2), was also genetically close to the contemporary human isolates. These findings suggest that the ancestor of the HA gene of MD4 virus was introduced from human populations around the end of the 20th century and has circulated and evolved in pig populations in Japan for more than a decade. Recently, Kanehira et al. also isolated an SIV of the H3N2 subtype from a pig in Japan that is genetically and antigenically related to human isolates from the 2000s (41) , suggesting that MD4 virus-like lineage may be established in Japanese pig populations.
The HA genes of both HY5 and YG5 viruses belong to the A(H1N1)pdm09 virus lineage in the phylogenetic tree of the H1 HA genes (Fig. 4) : however, these viruses share only 95.7% homology with each other and Ͻ97.8% homology with the genetically closest isolates in the database in the HA gene sequences (Table 3) . These findings suggest that the ancestor of the HA genes of HY5 and YG5 viruses were introduced from human populations after 2009 and have circulated and evolved in each of the pig populations individually. Overall, the SIVs isolated in this study are genetically unique, implying that a large number of SIV lineages may remain "undiscovered" in worldwide pig populations.
Here, we clarified the age-based SIV seroprevalence in pig populations by means of efficient and biologically contained microneutralization assays; growing pigs at 90 days old are most susceptible to SIV infection and thus are an ideal age group for SIV isolation (Fig. 1) . We isolated SIVs from this particular age group at a higher incidence than those of previous reports (Fig. 2) . Although other factors such as farming practices may affect the SIV circulation status in individual pig farms, we propose that the 90-day-old growing pig-targeted nasal swab collection presented in this study might facilitate global SIV surveillance and contribute to the detection and control of SIV infection.
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